Xiaofei Dai
Papers
8
Total Citations
283
H-Index
7
About
Xiaofei Dai is a pioneering urological surgeon and researcher at the forefront of robotic surgery innovation, with a primary focus on developing and validating next-generation surgical robotic systems. His most significant contributions center on the clinical translation of the KangDuo Surgical Robot (KD-SR-01), a domestically developed Chinese robotic platform designed to compete with the established da Vinci system. Through a series of landmark prospective clinical trials, Dai has systematically demonstrated the feasibility, safety, and noninferiority of the KangDuo robot for complex urological procedures, including robot-assisted radical prostatectomy, partial nephrectomy, and pyeloplasty. His work, which has collectively garnered over 280 citations, provides critical evidence supporting the adoption of this new technology, with key studies showing comparable perioperative outcomes to the da Vinci Si system. Notably, his 2022 study on robot-assisted partial nephrectomy, published as a prospective randomized controlled noninferiority trial, represents a milestone in the global competition among surgical robotic platforms. Dai’s research not only advances surgical robotics but also has profound implications for reducing healthcare costs and increasing access to minimally invasive surgery worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8